Fevziye Burcu ŞİRİN, Selma KORKMAZ, İjlal ERTURAN, Mehmet YILDIRIM, Halil İbrahim BÜYÜKBAYRAM

Coenzyme Q10, Zinc and MDA levels in verruca vulgaris

Background/aim: Verruca vulgaris is a benign disease characterized with papillomas on the skin and mucosa. The aim of this study was to investigate the serum levels of coenzyme Q10, MDA, and zinc as well as the lipid profile of verruca vulgaris patients and examine the relationship between these parameters and clinical manifestations of the disease. Materials and methods: The study included 49 verruca vulgaris patients (mean age: 32.01 ± 14.20 years; 22 males, 27 females) and 40 healthy volunteers (mean age: 31.63 ± 8.98 years; 21 males and 19 females). Coenzyme Q10 levels were assessed by using an enzymelinked immunosorbent assay. Serum MDA levels were measured spectrophotometrically. Zinc levels were measured using a Perkin Elmer AAnalyst 800 atomic absorption spectrometer with a deuterium background correction and additional standard techniques. Results: The coenzyme Q10 levels were found to be higher in the verruca vulgaris group compared to the healthy volunteers. However, this increase was not statistically significant (P = 0.195). Zinc levels were significantly lower in the verruca vulgaris group compared to the healthy volunteers (P = 0.002). In the patient group, MDA levels and HDL levels were significantly higher compared to the healthy volunteers (P = 0.023 and P = 0.004, respectively). Additionally, there was no statistically significant difference between the groups in the CoQ10/Total cholesterol ratio (P = 0.433). Conclusion: Reduced serum zinc levels and increase of oxidative stress in verruca vulgaris may be a factor responsible for development of verruca vulgaris.

PDF

___

1. Leung AK, Barankin B, Leong KF, Hon KL. Penile warts: an update on their evaluation and management. Drugs in Context 2018; 7: 212563. doi: 10.7573/dic.212563.
2. Sanclemente G, Gill DK. Human papillomavirus molecular biology and pathogenesis. Journal of the European Academy of Dermatology and Venereology 2002;16 (3): 231-240. doi: 10.1046/j.1473-2165.2002.00419.x
3. Mohamed EE, Tawfik KM, Mahmoud AM. The Clinical Effectiveness of Intralesional Injection of 2% Zinc Sulfate Solution in the Treatment of Common Warts. Scientifica 2016; 2016: 1082979. doi: 10.1155/2016/1082979
4. Gammoh NZ, Rink L. Zinc in Infection and Inflammation. Nutrients 2017; 9 (6): 624. doi: 10.3390/nu9060624
5. Arican O, Ozturk P, Kurutas EB, Unsal V. Status of oxidative stress on lesional skin surface of plantar warts. Journal of the European Academy of Dermatology and Venereology 2013; 27 (3): 365-369. doi: 10.1111/j.1468-3083.2011.04419.x
6. Farough S, Karaa A, Walker MA, Slate N, Dasu T et al. Coenzyme Q10 and immunity: A case report and new implications for treatment of recurrent infections in metabolic diseases. Clinical immunology 2014; 155 (2): 209-212. doi: 10.1016/j.clim.2014.09.010
7. Flowers N, Hartley L, Todkill D, Stranges S, Rees K. Coenzyme Q10 supplementation for the primary prevention of cardiovascular disease. The Cochrane database of systematic reviews 2014; (12): CD010405. doi: 10.1002/14651858.
8. Samimi M, Zarezade Mehrizi M, Foroozanfard F, Akbari H, Jamilian M et al. The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clinical Endocrinology 2017; 86 (4): 560-566. doi: 10.1111/cen.13288
9. Draper HH, Hadley M. Malondialdehyde determinationas index of lipid peroxidation. Methods in Enzymology 1990; 186: 421-431. doi: 10.1016/0076-6879(90)86135-i
10. Smith JC Jr, Butrimovitz GP, Purdy WC. Direct measurement of zinc in plasma by atomic absorption spectroscopy. Clinical Chemistry 1979; 25 (8): 1487-1491.
11. Wong CP, Dashner-Titus EJ, Alvarez SC, Chase TT, Hudson LG et al. Zinc Deficiency and Arsenic Exposure Can Act Both Independently or Cooperatively to Affect Zinc Status, Oxidative Stress, and Inflammatory Response. Biological Trace Element Research 2019; 91 (2): 370-381. doi: 10.1007/s12011- 019-1631
12. Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebocontrolled clinical trial. British Journal of Dermatology 2002; 146 (3): 423-431. doi: 10.1046/j.1365-2133.2002.04617.x
13. Rodríguez-Menéndez S, García M, Fernández B, Álvarez L, Fernández-Vega-Cueto A et al. The zinc-metallothionein redox system reduces oxidative stress in retinal pigmnet epithelial cells. Nutrients 2018; 10 (12): 1874. doi: 10.3390/nu10121874
14. El Taweel AA, Salem R, Allam A. Intralesional 2% zinc sulfate solution for plane warts: A case report. Dermatologic Therapy 2018; 32 (1): 12761. doi: 10.1111/dth.12761
15. Akhavan S, Mohammadi SR, Modarres Gillani M, Mousavi AS, Shirazi M. Efficacy of combination therapy of oral zinc sulfate with imiquimod, podophyllin or cryotherapy in the treatment of vulvar warts. The Journal of Obstetrics and Gynaecology Research 2014; 40 (10): 2110-2113. doi: 10.1111/jog.12457
16. Mahmoudi H, Ghodsi SZ, Tavakolpour S, Daneshpazhooh M. Cryotherapy plus oral zinc sulfate versus cryotherapy plus plecabo to treat common warts: A double blind, randomized, plecabo-controlled trial. International Journal of Women’s Dermatology 2017; 4 (2): 87-90. doi: 10.1016/j.ijwd.2017.09.004
17. Yaghoobi R, Sadighha A, Baktash D. Evaluation of oral zinc sulfate effect on recalcitran multiple viral warts: A randomized plecabo-controlled clinical trial. Journal of the American Academy of Dermatology 2009; 60 (4): 706-708. doi: 10.1016/j. jaad.2008.09.010
18. Larbi A, Kempf J, Pawelec G. Oxidative stress modulation and T cell activation. Experimental Gerontology 2007; 42 (9): 852- 858. doi: 10.1016/j.exger.2007.05.004
19. Cokluk E, Sekeroglu MR, Aslan M, Balahoroglu R, Bilgili SG et al. Determining oxidant and antioxidant status in patients with genital warts. Redox Report: Communications in Free Radical Research 2015; 20 (5): 210-214. doi: 10.1179/1351000215Y.0000000002
20. Kaya Y, Çebı A, Söylemez N, Demır H, Alp HH et al. Correlations between oxidative DNA damage, oxidative stress and coenzyme Q10 in patients with coronary artery disease. International Journal of Medical Sciences 2012; 9 (8): 621-626. doi: 10.7150/ijms.4768
21. De Luca C, Kharaeva Z, Raskovic D, Pastore P, Luci A et al. Coenzyme Q(10), vitamin E, selenium, and methionine in the treatment of chronic recurrent viral mucocutaneous infections. Nutrition 2012; 28 (5): 509-514. doi: 10.1016/j.nut.2011.08.003
22. De Bustos F, Molina JA, Jiménez-Jiménez FJ, GarcíaRedondo A, Gómez-Escalonilla C et al. Serum levels of coenzyme Q10 in patients with Alzheimer’s disease. Journal of Neural Transmission 2000; 107 (2): 233-239. doi: 10.1007/ s007020050019